A multicenter collaborative study on the risk factors of cardiac sequelae due to Kawasaki disease: a one‐year follow‐up study

Objective: To measure the prevalence of cardiac sequelae 1 y after the onset of Kawasaki disease and determine the risk factors associated with these cardiac sequelae. Material and methods: 1594 patients who initially visited one of the 87 target hospitals in 1996 for Kawasaki disease participated. Selection of the target hospitals was based on a nationwide survey. The patients were followed‐up and information concerning cardiac sequelae occurring within 1 y of onset was obtained by mail survey. Results: The prevalence of cardiac sequelae 1 mo after onset was 10.2% and decreased to 4.2% in 1 y. The prevalence was higher among males than females and higher in patients less than 1 y and 5 ys or older than in 1–4 year‐olds. Of the patients with cardiac sequelae at 1 mo, the sequelae disappeared in 60.7% after 1 y. Analysis revealed low serum albumin as a risk factor related to the occurrence of cardiac sequelae 1 y after onset. Of the 1594 patients, 10 had giant anuerysms and 3 had a fatal outcome.

[1]  H Yanagawa,et al.  Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. , 1998, Pediatrics.

[2]  A. Beiser,et al.  A Predictive Instrument for Coronary Artery Aneurysms in Kawasaki Disease 11This study was supported, in part, by grants HL34545 and HL48606 from the National Institutes of Health, Bethesda, Maryland, and by the Kobren Fund, Boston, Massachusetts. , 1998 .

[3]  H. Yanagawa,et al.  Cardiac sequelae of Kawasaki disease among recurrent cases , 1998, Archives of disease in childhood.

[4]  K Hashino,et al.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. , 1996, Circulation.

[5]  H. Aotsuka,et al.  Thrombocytopenia: a risk factor for acute myocardial infarction during the acute phase of Kawasaki disease. , 1995, Coronary artery disease.

[6]  H. Yanagawa,et al.  Iv gamma globulin treatment of Kawasaki disease in Japan: results of a nationwide survey , 1995, Acta paediatrica.

[7]  H. Yanagawa,et al.  Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. , 1995, Pediatrics.

[8]  Y. Arakaki,et al.  Fate of coronary arterial aneurysms in Kawasaki disease. , 1994, The American journal of cardiology.

[9]  K. Harada Intravenous γ‐Globulin Treatment in Kawasaki Disease , 1991 .

[10]  W. Neches,et al.  The value of angiography in the follow-up of coronary involvement in mucocutaneous lymph node syndrome (Kawasaki disease). , 1989, Journal of the American College of Cardiology.

[11]  A. Lewis,et al.  Regression of coronary aneurysms in patients with Kawasaki syndrome. , 1987, Circulation.

[12]  S. Daniels,et al.  Correlates of coronary artery aneurysm formation in patients with Kawasaki disease. , 1987, American journal of diseases of children.

[13]  H. Nakano,et al.  Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms. , 1986, The American journal of cardiology.

[14]  H. Kato,et al.  Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. , 1982, The American journal of cardiology.

[15]  T. Kawasaki,et al.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. , 1967, Arerugi = [Allergy].

[16]  H. Yanagawa,et al.  Changes in epidemic patterns of Kawasaki disease in Japan. , 1999, The Pediatric infectious disease journal.

[17]  M. Iwasa,et al.  Selection of high-risk children for immunoglobulin therapy in Kawasaki disease. , 1987, Progress in clinical and biological research.